ะ—ะฐะณั€ัƒะทะบะฐ ะฒะธะดะตะพ...

ะะต ัƒะดะฐะปะพััŒ ะทะฐะณั€ัƒะทะธั‚ัŒ ะฒะธะดะตะพ

ะะฐ ะณะปะฐะฒะฝัƒัŽ

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: AstraZeneca's CEO Pascal Soriot shares his take on M&A, oncology, Baxfendy for hypertension, the obesity market, and more. $AZN Full video:

BiotechTV's profile picture

BiotechTV

11,775 subscribers

36,428 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 3 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด โ€ขvia X (Twitter)

LIVE

Anya Rossiโ€ข Live Now

Private livecam show

ะšะพะผะผะตะฝั‚ะฐั€ะธะธ: 0

ะะตั‚ ะดะพัั‚ัƒะฟะฝั‹ั… ะบะพะผะผะตะฝั‚ะฐั€ะธะตะฒ

ะ—ะดะตััŒ ะฟะพัะฒัั‚ัั ะบะพะผะผะตะฝั‚ะฐั€ะธะธ ะธะท ะพั€ะธะณะธะฝะฐะปัŒะฝะพะณะพ ะฟะพัั‚ะฐ

ะŸะพั…ะพะถะธะต ะฒะธะดะตะพ

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: ArsenalBio Co-Founder & CEO ken drazan talks about engineering the next generation of T-cell therapies, including a clinical stage renal cell program that includes multiple features. Full video:
3:45

๐…๐ซ๐จ๐ฆ ๐๐˜๐’๐„: ArsenalBio Co-Founder & CEO ken drazan talks about engineering the next generation of T-cell therapies, including a clinical stage renal cell program that includes multiple features. Full video:

BiotechTV

11,057 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 1 ะณะพะด ะฝะฐะทะฐะด

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset. $OLEM Full video:
4:00

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset. $OLEM Full video:

BiotechTV

12,936 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 10 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

.AstraZeneca CEO Pascal Soriot: "Today, I'm really excited to announce AstraZeneca's commitment to your vision for a healthier America... about lowering the price of medicines for American patients, while ensuring that America remains the global powerhouse of innovation and biopharmaceuticals."
5:32

.AstraZeneca CEO Pascal Soriot: "Today, I'm really excited to announce AstraZeneca's commitment to your vision for a healthier America... about lowering the price of medicines for American patients, while ensuring that America remains the global powerhouse of innovation and biopharmaceuticals."

Rapid Response 47

91,476 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 11 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026. Full video:
3:49

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Perceptive Advisors' Joe Edelman, one of the top investors in biotech, shares his investment philosophy and his take on the sector heading into 2026. Full video:

BiotechTV

25,829 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 8 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐…๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐๐š๐ฒ ๐€๐ซ๐ž๐š: Gordian Biotechnology announced that it will be using its unique large-scale in vivo screening process to help Pfizer look for new targets against obesity. Co Founder & CSO Martin Borch Jensen explains how it works. Full video:
2:56

๐…๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐๐š๐ฒ ๐€๐ซ๐ž๐š: Gordian Biotechnology announced that it will be using its unique large-scale in vivo screening process to help Pfizer look for new targets against obesity. Co Founder & CSO Martin Borch Jensen explains how it works. Full video:

BiotechTV

13,213 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 7 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, Thilo Schroeder describes his investment philosophy and focus on precision oncology. Full video:
8:50

๐๐ข๐จ๐•๐ž๐ง๐ญ๐ฎ๐ซ๐ž ๐•๐จ๐ข๐‚๐ž๐ฌ: An early investor in recent mega successes such as Revolution Medicines, Peloton, Blueprint Medicines, and Parabilis, Thilo Schroeder describes his investment philosophy and focus on precision oncology. Full video:

BiotechTV

13,827 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 3 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:
4:30

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and comments on a few of his firm's top positions. $XBI $XENE $MDGL $ALKS Full video:

BiotechTV

13,777 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 10 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:
6:11

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:

BiotechTV

11,722 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 4 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ก๐ฎ๐ซ๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:
3:27

๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ญ ๐“๐ก๐ฎ๐ซ๐ฌ๐๐š๐ฒ๐ฌ: Mizuho Senior Biotech Analyst Graig Suvannavejh shares his take on three key biotech trials that are scheduled to read out soon, and one that recently happened. $IDYA $EYPT $OCUL $PVLA $CRVS Full video:

BiotechTV

29,397 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 7 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:
3:36

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:

BiotechTV

20,950 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 1 ะณะพะด ะฝะฐะทะฐะด

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’: Legend Biotech CEO Ying Huang on moving Carvykti into earlier settings, potential future competition, beyond BCMA, and more. #ASH24 $LEGN Full video:
0:48

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’: Legend Biotech CEO Ying Huang on moving Carvykti into earlier settings, potential future competition, beyond BCMA, and more. #ASH24 $LEGN Full video:

BiotechTV

17,521 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 1 ะณะพะด ะฝะฐะทะฐะด

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:
3:51

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:

BiotechTV

73,893 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 8 ะผะตััั†ะตะฒ ะฝะฐะทะฐะด

๐”.๐’. ๐’๐œ๐ข๐ž๐ง๐œ๐ž ๐’๐ฎ๐ฆ๐ฆ๐ข๐ญ: Alexis Borisy shares his take on one of today's biggest debates in biotech, the impact of China on the U.S. biotech sector.
4:15

๐”.๐’. ๐’๐œ๐ข๐ž๐ง๐œ๐ž ๐’๐ฎ๐ฆ๐ฆ๐ข๐ญ: Alexis Borisy shares his take on one of today's biggest debates in biotech, the impact of China on the U.S. biotech sector.

BiotechTV

12,238 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 1 ะผะตััั† ะฝะฐะทะฐะด

๐…๐ซ๐จ๐ฆ ๐’๐ž๐จ๐ฎ๐ฅ: Daejeon based Orum Therapeutics is pioneering the field of degrader-antibody conjugates. Founder SJ Lee describes the science and gives us an overview of biotech in Korea. Full video:
4:12

๐…๐ซ๐จ๐ฆ ๐’๐ž๐จ๐ฎ๐ฅ: Daejeon based Orum Therapeutics is pioneering the field of degrader-antibody conjugates. Founder SJ Lee describes the science and gives us an overview of biotech in Korea. Full video:

BiotechTV

15,588 ะฟั€ะพัะผะพั‚ั€ะพะฒ โ€ข 1 ะณะพะด ะฝะฐะทะฐะด